Abstract
The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was initially described in late 2019 in Wuhan City, China, and was reported to the World Health Organization (WHO) in December 2019 (Wang et al. 2020). The virus was identified among patients who had pneumonia and were linked to a wet-seafood market. This virus was initially known as novel coronavirus 2019 (nCoV-19) and then later was designated as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) (Gorbalenya et al. 2020). This chapter summarizes the current understanding of the disease, the emergence of variants, and outcome.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Agarwal N, Mishra S, Ayub A (2021) Convalescent plasma therapy in COVID-19 and discharge status: a systematic review. J Family Med Prim Care 10:3876. https://doi.org/10.4103/JFMPC.JFMPC_2429_20
Ahava MJ, Kurkela S, Kuivanen S, Lappalainen M, Jarva H, Jääskeläinen AJ (2022) Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infection. J Virol Methods 302:114469. https://doi.org/10.1016/j.jviromet.2022.114469
Al Hammadi ZM, Chu DKW, Eltahir YM, Al Hosani F, Al Mulla M, Tarnini W et al (2015) Asymptomatic MERS-CoV infection in humans possibly linked to infected dromedaries imported from Oman to United Arab Emirates, may 2015. Emerg Infect Dis 21:2197–2200. https://doi.org/10.3201/eid2112.151132
Alagaili AN, Briese T, Mishra N, Kapoor V, Sameroff SC, de Wit E et al (2014) Middle east respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. MBio 5:e00884-14. https://doi.org/10.1128/mBio.00884-14
Alexandersen S, Kobinger GP, Soule G, Wernery U (2014) Middle east respiratory syndrome coronavirus antibody reactors among camels in Dubai, United Arab Emirates, in 2005. Transbound Emerg Dis 61:105–108. https://doi.org/10.1111/tbed.12212
Alhumaid S, Al Mutair A, Al Alawi Z, Alshawi AM, Alomran SA, Almuhanna MS et al (2021) Coinfections with bacteria, fungi, and respiratory viruses in patients with sars-cov-2: a systematic review and meta-analysis. Pathogens 10. https://doi.org/10.3390/pathogens10070809
Alimohamadi Y, Sepandi M, Taghdir M, Hosamirudsari H (2020) Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis. J Prev Med Hyg 61:E304–E312. https://doi.org/10.15167/2421-4248/JPMH2020.61.3.1530
Al-Tawfiq JA, Zumla A, Memish ZA (2014) Coronaviruses: severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus in travelers. Curr Opin Infect Dis 27:411–417. https://doi.org/10.1097/QCO.0000000000000089
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R et al (2021) Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384:403–416. https://doi.org/10.1056/nejmoa2035389
Baradaran A, Ebrahimzadeh MH, Baradaran A, Kachooei AR (2020) Prevalence of comorbidities in COVID-19 patients: a systematic review and meta-analysis. Arch Bone Jt Surg 8(1):247–255. https://doi.org/10.22038/abjs.2020.47754.2346
Briese T, Mishra N, Jain K, Zalmout IS, Jabado OJ, Karesh WB et al (2014) Middle east respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole- genome analysis and virus cultured from dromedary camels in Saudi Arabia. MBio 5. https://doi.org/10.1128/mBio.01146-14
Buonsenso D, Munblit D, De Rose C, Sinatti D, Ricchiuto A, Carfi A et al (2021) Preliminary evidence on long COVID in children. Acta Paediatr 110:2208–2211. https://doi.org/10.1111/APA.15870
Burki TK (2021) Omicron variant and booster COVID-19 vaccines. Lancet Respir Med 10:e17. https://doi.org/10.1016/S2213-2600(21)00559-2
Cele S, Jackson L, Khoury DS, Khan K, Moyo-Gwete T, Tegally H et al (2021) SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. MedRxiv Preprint 11:12. https://doi.org/10.1101/2021.12.08.21267417
Cénat JM, Blais-Rochette C, Kokou-Kpolou CK, Noorishad PG, Mukunzi JN, McIntee SE et al (2021) Prevalence of symptoms of depression, anxiety, insomnia, posttraumatic stress disorder, and psychological distress among populations affected by the COVID-19 pandemic: a systematic review and meta-analysis. Psychiatry Res 295:113599. https://doi.org/10.1016/j.psychres.2020.113599
Centers for Disease Control and Prevention (CDC). SARS-CoV-2 Variant Classifications and Definitions 2021. https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fcases-updates%2Fvariant-surveillance%2Fvariant-info.html. Accessed 16 Aug 2021
Chan JFW, Lau SKP, To KKW, Cheng VCC, Woo PCY, Yuen K-Y (2015) Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev 28:465–522. https://doi.org/10.1128/CMR.00102-14
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507–513. https://doi.org/10.1016/S0140-6736(20)30211-7
Cheng Q, Zhao G, Chen J, Jia Q, Fang Z (2021) Efficacy and safety of current treatment interventions for patients with severe COVID-19 infection: a network meta-analysis of randomized controlled trials. J Med Virol 94:1617. https://doi.org/10.1002/JMV.27512
Choi JH, Choi S-H, Yun KW (2022) Risk factors for severe COVID-19 in children: a systematic review and meta-analysis. J Korean Med Sci 37. https://doi.org/10.3346/jkms.2022.37.e35
Chopra V, Flanders SA, O’Malley M, Malani AN, Prescott HC (2021) Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med 174:576–578. https://doi.org/10.7326/M20-5661
Cohen J (2021) Omicron sparks a vaccine strategy debateCurrent boosters, variant-specific shots, and universal coronavirus vaccines all have fans. Science (80-) 374:1544–1545
Corman VM, Jores J, Meyer B, Younan M, Liljander A, Said MY et al (2014) Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992-2013. Emerg Infect Dis 20:1319–1322. https://doi.org/10.3201/eid2008.140596
Corman VM, Baldwin HJ, Tateno AF, Zerbinati RM, Annan A, Owusu M et al (2015) Evidence for an ancestral Association of Human Coronavirus 229E with bats. J Virol 89:11858–11870. https://doi.org/10.1128/jvi.01755-15
Crossley BM, Mock RE, Callison SA, Hietala SK (2012) Identification and characterization of a novel alpaca respiratory coronavirus most closely related to the human coronavirus 229E. Viruses 4:3689–3700. https://doi.org/10.3390/v4123689
Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y et al (2021) Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38:101019. https://doi.org/10.1016/j.eclinm.2021.101019
Decaro N, Lorusso A (2020) Novel human coronavirus (SARS-CoV-2): a lesson from animal coronaviruses. Vet Microbiol 244:108693. https://doi.org/10.1016/j.vetmic.2020.108693
Dejnirattisai W, Shaw RH, Supasa P, Liu C, Stuart AS, Pollard AJ et al (2021) Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum. Lancet. https://doi.org/10.1016/S0140-6736(21)02844-0
Deng Q, Ye G, Pan Y, **e W, Yang G, Li Z et al (2021) High performance of SARS-Cov-2N protein antigen chemiluminescence immunoassay as frontline testing for acute phase COVID-19 diagnosis: a retrospective cohort study. Front Med 8:871. https://doi.org/10.3389/FMED.2021.676560/BIBTEX
Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L et al (2020) Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 369. https://doi.org/10.1136/bmj.m1985
Du L, He Y, Zhou Y, Liu S, Zheng B-J, Jiang S (2009) The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol 7:226–236. https://doi.org/10.1038/nrmicro2090
ECDC. Threat Assessment Brief: emergence of SARS-CoV-2 B.1.617 variants in India and situation in the EU/EEA 2021. https://www.ecdc.europa.eu/en/publications-data/threat-assessment-emergence-sars-cov-2-b1617-variants. Accessed 16 Aug 2021
Farag EABA, Reusken CBEM, Haagmans BL, Mohran KA, Stalin Raj V, Pas SD et al (2015) High proportion of MERS-CoV shedding dromedaries at slaughterhouse with a potential epidemiological link to human cases, Qatar 2014. Infect Ecol Epidemiol 5:28305
Ferré VM, Peiffer-Smadja N, Visseaux B, Descamps D, Ghosn J, Charpentier C (2021) Omicron SARS-CoV-2 variant: what we know and what we don’t. Anaesth Crit Care Pain Med 41:100998. https://doi.org/10.1016/j.accpm.2021.100998
Giannouchos TV, Sussman RA, Mier JM, Poulas K, Farsalinos K (2020) Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory–confirmed COVID-19 cases. Eur Respir J:2002144. https://doi.org/10.1183/13993003.02144-2020
Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA et al (2020) The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 5:536–544. https://doi.org/10.1038/s41564-020-0695-z
Graham F (2021) Daily briefing: Omicron - what scientists know so far. Nature. https://doi.org/10.1038/D41586-021-03652-7
Greaney AJ, Starr TN, Gilchuk P, Zost SJ, Binshtein E, Loes AN et al (2021) Complete map** of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host Microb 29:44–57.e9. https://doi.org/10.1016/j.chom.2020.11.007
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J et al (2020a) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708–1720. https://doi.org/10.1056/NEJMoa2002032
Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM et al (2020b) Comorbidity and its impact on 1,590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J 55:2000547. https://doi.org/10.1183/13993003.00547-2020
Haagmans BL, Al Dhahiry SHS, Reusken CBEM, Raj VS, Galiano M, Myers R et al (2014) Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis 14:140–145. https://doi.org/10.1016/S1473-3099(13)70690-X
He X, Hong W, Pan X, Lu G, Wei X (2021) SARS-CoV-2 omicron variant: characteristics and prevention. MedComm 2:838–845. https://doi.org/10.1002/MCO2.110
Hemida MG, Perera RA, Wang P, Alhammadi MA, Siu LY, Li M et al (2013) Middle east respiratory syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013. Eur Secur 18. https://doi.org/10.2807/1560-7917.ES2013.18.50.20659
Hemida MG, Perera RA, Al Jassim RA, Kayali G, Siu LY, Wang P et al (2014a) Seroepidemiology of middle east respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Eur Secur 19:20828
Hemida MG, Chu DKW, Poon LLM, Perera RAPM, Alhammadi MA, Ng H-Y et al (2014b) MERS coronavirus in dromedary camel herd, Saudi Arabia. Emerg Infect Dis 20:1231–1234. https://doi.org/10.3201/eid2007.140571
Hemida MG, Alnaeem A, Chu DK, Perera RA, Chan SM, Almathen F et al (2017) Longitudinal study of Middle East Respiratory Syndrome coronavirus infection in dromedary camel herds in Saudi Arabia, 2014-2015. Emerg Microbes Infect 6:e56. https://doi.org/10.1038/emi.2017.44
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271–280.e8. https://doi.org/10.1016/j.cell.2020.02.052
Holmes EC, Goldstein SA, Rasmussen AL, Robertson DL, Crits-Christoph A, Wertheim JO et al (2021) The origins of SARS-CoV-2: a critical review. Cell 184:4848–4856. https://doi.org/10.1016/j.cell.2021.08.017
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020a) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497. https://doi.org/10.1016/S0140-6736(20)30183-5
Huang Y, Yang C, Xu XF, Xu W, Liu SW (2020b) Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin 41:1141–1149. https://doi.org/10.1038/s41401-020-0485-4
Kamal M, Abo Omirah M, Hussein A, Saeed H (2021) Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract 75. https://doi.org/10.1111/IJCP.13746
Kayaaslan B, Eser F, Kalem AK, Kaya G, Kaplan B, Kacar D et al (2021) Post-COVID syndrome: a single-center questionnaire study on 1007 participants recovered from COVID-19. J Med Virol 93:6566–6574. https://doi.org/10.1002/JMV.27198
Khalafalla AI, Lu X, Al-Mubarak AI, Dalab AH, Al-Busadah KA, Erdman DD (2015) MERS-CoV in upper respiratory tract and lungs of dromedary camels, Saudi Arabia, 2013-2014. Emerg Infect Dis 21:1153–1158. https://doi.org/10.3201/eid2107.150070
Krammer F (2020) SARS-CoV-2 vaccines in development. Nature 586:516–527. https://doi.org/10.1038/s41586-020-2798-3
Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S et al (2020) Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581:215–220. https://doi.org/10.1038/s41586-020-2180-5
Le Hingrat Q, Visseaux B, Laouenan C, Tubiana S, Bouadma L, Yazdanpanah Y et al (2021) Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives. Clin Microbiol Infect 27:789.e1–789.e5. https://doi.org/10.1016/j.cmi.2020.11.025
Lebedin YS, Lyang OV, Galstyan AG, Belousov VV, Rebrikov DV (2020) Serum SARS-CoV-2 nucleocapsid antigen detection is essential for primary diagnostics of SARS-CoV-2-associated pneumonia. MedRxiv:2020.09.24.20200303. https://doi.org/10.1101/2020.09.24.20200303
Li J, Huang DQ, Zou B, Yang H, Hui WZ, Rui F et al (2021) Epidemiology of COVID-19: a systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol 93:1449–1458. https://doi.org/10.1002/JMV.26424
Lisboa Bastos M, Tavaziva G, Abidi SK, Campbell JR, Haraoui LP, Johnston JC et al (2020) Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis. BMJ 370:2516. https://doi.org/10.1136/bmj.m2516
Liu C, Ginn HM, Dejnirattisai W, Supasa P, Wang B, Tuekprakhon A et al (2021) Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum. Cell 184:4220–4236.e13. https://doi.org/10.1016/j.cell.2021.06.020
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395:565–574. https://doi.org/10.1016/S0140-6736(20)30251-8
Lu L, Mok BW-Y, Chen L-L, Chan JM-C, Tsang OT-Y, Lam BH-S et al (2021) Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or CoronaVac vaccine recipients. Clin Infect Dis 75:e822. https://doi.org/10.1093/cid/ciab1041
Memish ZA, Mishra N, Olival KJ, Fagbo SF, Kapoor V, Epstein JH et al (2013) Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis 19:1819–1823. https://doi.org/10.3201/eid1911.131172
Menges D, Ballouz T, Anagnostopoulos A, Aschmann HE, Domenghino A, Fehr JS et al (2021) Burden of post-COVID-19 syndrome and implications for healthcare service planning: a population-based cohort study. PLoS One 16. https://doi.org/10.1371/JOURNAL.PONE.0254523
Michielsen HJ, De Vries J, Van Heck GL (2003) Psychometric qualities of a brief self-rated fatigue measure: the Fatigue Assessment Scale. J Psychosom Res 54:345–352. https://doi.org/10.1016/S0022-3999(02)00392-6
Moreno-Pérez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jiménez J et al (2021) Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect 82:378–383. https://doi.org/10.1016/J.JINF.2021.01.004
Morens DM, Taubenberger JK, Fauci AS (2021) Universal coronavirus vaccines — an urgent need. N Engl J Med 386:297. https://doi.org/10.1056/nejmp2118468
Norton A, Olliaro P, Sigfrid L, Carson G, Paparella G, Hastie C et al (2021) Long COVID: tackling a multifaceted condition requires a multidisciplinary approach. Lancet Infect Dis 21:601–602. https://doi.org/10.1016/S1473-3099(21)00043-8
Nowotny N, Kolodziejek J (2014) Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels, Oman, 2013. Euro Surveill 19:20781. https://doi.org/10.2807/1560-7917.ES2014.19.16.20781
Ogata AF, Maley AM, Wu C, Gilboa T, Norman M, Lazarovits R et al (2020) Ultra-sensitive serial profiling of SARS-CoV-2 antigens and antibodies in plasma to understand disease progression in COVID-19 patients with severe disease. Clin Chem 66:1562–1572. https://doi.org/10.1093/clinchem/hvaa213
Okba NMA, Müller MA, Li W, Wang C, GeurtsvanKessel CH, Corman VM et al (2020) Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients. Emerg Infect Dis 26. https://doi.org/10.3201/eid2607.200841
Petherick A (2020) Develo** antibody tests for SARS-CoV-2. Lancet 395:1101–1102. https://doi.org/10.1016/s0140-6736(20)30788-1
Planas D, Veyer D, Baidaliuk A, Staropoli I, Guivel-Benhassine F, Rajah MM et al (2021) Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature 596:276–280. https://doi.org/10.1038/s41586-021-03777-9
Pulliam JRC, van Schalkwyk C, Govender N, von Gottberg A, Cohen C, Groome MJ et al (2021) Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa. MedRxiv 2021(11):11.21266068. https://doi.org/10.1101/2021.11.11.21266068
Qiu P, Zhou Y, Wang F, Wang H, Zhang M, Pan X et al (2020) Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis. Aging Clin Exp Res 32:1869–1878. https://doi.org/10.1007/s40520-020-01664-3
Quarleri J, Galvan V, Delpino MV (2021) Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load. GeroScience 44:53. https://doi.org/10.1007/S11357-021-00500-4
Rambaut A, Holmes EC, O’Toole Á, Hill V, McCrone JT, Ruis C et al (2020) A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol 5:1403–1407. https://doi.org/10.1038/s41564-020-0770-5
RECOVERY Collaborative Group (2020) Dexamethasone in hospitalized patients with Covid-19 — Preliminary report. N Engl J Med. https://doi.org/10.1056/nejmoa2021436
Reusken CBEM, Haagmans BL, Müller MA, Gutierrez C, Godeke GJ, Meyer B et al (2013a) Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis 13:859–866. https://doi.org/10.1016/S1473-3099(13)70164-6
Reusken CB, Ababneh M, Raj VS, Meyer B, Eljarah A, Abutarbush S et al (2013b) Middle east respiratory syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, june to September 2013. Eur Secur 18. https://doi.org/10.2807/1560-7917.ES2013.18.50.20662
Reusken CBEM, Messadi L, Feyisa A, Ularamu H, Godeke GJ, Danmarwa A et al (2014) Geographic distribution of MERS coronavirus among dromedary camels, Africa. Emerg Infect Dis 20:1370–1374. https://doi.org/10.3201/eid2008.140590
Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H et al (2020) Structural basis of receptor recognition by SARS-CoV-2. Nature 581:221–224. https://doi.org/10.1038/S41586-020-2179-Y
Stalin Raj V, Farag EABA, Reusken CBEM, Lamers MM, Pas SD, Voermans J et al (2014) Isolation of MERS coronavirus from dromedary camel, Qatar, 2014. Emerg Infect Dis 20:1339–1342. https://doi.org/10.3201/eid2008.140663
Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC et al (2021) Attributes and predictors of long COVID. Nat Med 27:626–631. https://doi.org/10.1038/S41591-021-01292-Y
Tao Y, Shi M, Chommanard C, Queen K, Zhang J, Markotter W et al (2017) Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history. J Virol 91:e01953–e01916. https://doi.org/10.1128/jvi.01953-16
Temsah MH, Barry M, Aljamaan F, Alhuzaimi AN, Al-Eyadhy A, Saddik B et al (2021) SARS-CoV-2 B.1.1.7 UK variant of concern lineage-related perceptions, COVID-19 vaccine acceptance and travel worry among healthcare workers. Front Public Health:9. https://doi.org/10.3389/fpubh.2021.686958
Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC et al (2020) Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep 69:993–998. https://doi.org/10.15585/MMWR.MM6930E1
Thakur V, Kanta Ratho R (2021) OMICRON (B.1.1.529): a new SARS-CoV-2 variant of concern mounting worldwide fear. J Med Virol. https://doi.org/10.1002/JMV.27541
Tian Y, Wu Q, Li H, Wu Q, **e Y, Li L et al (2022) Distinct symptoms and underlying comorbidities with latitude and longitude in COVID-19: a systematic review and meta-analysis. Can Respir J 2022:1–11. https://doi.org/10.1155/2022/6163735
Tirupathi R, Muradova V, Shekhar R, Salim SA, Al-Tawfiq JA, Palabindala V (2020) COVID-19 disparity among racial and ethnic minorities in the US: a cross sectional analysis. Travel Med Infect Dis 38:101904. https://doi.org/10.1016/j.tmaid.2020.101904
Troxel AB, Petkova E, Goldfeld K, Liu M, Tarpey T, Wu Y et al (2022) Association of convalescent plasma treatment with clinical status in patients hospitalized with COVID-19: a meta-analysis. JAMA Netw Open 5:e2147331. https://doi.org/10.1001/JAMANETWORKOPEN.2021.47331
Van Der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RJM, Wolthers KC et al (2004) Identification of a new human coronavirus. Nat Med 10:368–373. https://doi.org/10.1038/nm1024
van Kasteren PB, van der Veer B, van den Brink S, Wijsman L, de Jonge J, van den Brandt A et al (2020) Comparison of seven commercial RT-PCR diagnostic kits for COVID-19. J Clin Virol 128:104412. https://doi.org/10.1016/j.jcv.2020.104412
Vengesai A, Midzi H, Kasambala M, Mutandadzi H, Mduluza-Jokonya TL, Rusakaniko S et al (2021) A systematic and meta-analysis review on the diagnostic accuracy of antibodies in the serological diagnosis of COVID-19. Syst Rev 10:1–23. https://doi.org/10.1186/s13643-021-01689-3
Wang C, Horby PW, Hayden FG, Gao GF (2020) A novel coronavirus outbreak of global health concern. Lancet 395:470–473. https://doi.org/10.1016/S0140-6736(20)30185-9
Wernery U, Corman VM, Wong EYM, Tsang AKL, Muth D, Lau SKP et al (2015) Acute Middle East respiratory syndrome coronavirus infection in livestock dromedaries, Dubai, 2014. Emerg Infect Dis 21:1019–1022. https://doi.org/10.3201/eid2106.150038
Wibmer CK, Ayres F, Hermanus T, Madzivhandila M, Kgagudi P, Oosthuysen B et al (2021) SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Nat Med 27:622–625. https://doi.org/10.1038/S41591-021-01285-X
Wilhelm A, Widera M, Grikscheit K, Toptan T, Schenk B, Pallas C et al (2021) Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies. MedRxiv 2021(12):07.21267432. https://doi.org/10.1101/2021.12.07.21267432
Woo PCY, Lau SKP, Chu C, Chan K, Tsoi H, Huang Y et al (2005) Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 79:884–895. https://doi.org/10.1128/jvi.79.2.884-895.2005
World Health Organization (WHO) (2021a) Enhancing Readiness for Omicron (B.1.1.529): Technical Brief and Priority Actions for Member States. World Heal Organ HQ:1–8. https://www.who.int/publications/m/item/enhancing-readiness-for-omicron-(b.1.1.529)-technical-brief-and-priority-actions-for-member-states. Accessed 25 Dec 2021
World Health Organization (WHO). Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern 2021. https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern. Accessed 10 Dec 2021b
World Health Organization (WHO). Tracking SARS-CoV-2 variants 2021. https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/. Accessed 2 June 2021c
Wrobel AG, Benton DJ, Xu P, Roustan C, Martin SR, Rosenthal PB et al (2020) SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects. Nat Struct Mol Biol 27:763–767. https://doi.org/10.1038/s41594-020-0468-7
Yadav PD, Sapkal GN, Abraham P, Ella R, Deshpande G, Patil DY et al (2021) Neutralization of variant under investigation B.1.617.1 with sera of BBV152 vaccinees. Clin Infect Dis. https://doi.org/10.1093/cid/ciab411
Yusof MF, Eltahir YM, Serhan WS, Hashem FM, Elsayed EA, Marzoug BA et al (2015) Prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Abu Dhabi Emirate, United Arab Emirates. Virus Genes 50:509–513. https://doi.org/10.1007/s11262-015-1174-0
Zhang W, Du RH LB, Zheng XS, Yang XL, Hu B et al (2020) Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 9:386–389. https://doi.org/10.1080/22221751.2020.1729071
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al (2020) A novel coronavirus from patients with Pneumonia in China, 2019. N Engl J Med:NEJMoa2001017. https://doi.org/10.1056/NEJMoa2001017
Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z et al (2020) SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 382:1177–1179. https://doi.org/10.1056/nejmc2001737
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Al-Tawfiq, J.A., Memish, Z.A. (2023). Severe Acute Respiratory Syndrome Coronaviruses-2 (SARS-CoV-2). In: Sing, A. (eds) Zoonoses: Infections Affecting Humans and Animals. Springer, Cham. https://doi.org/10.1007/978-3-031-27164-9_50
Download citation
DOI: https://doi.org/10.1007/978-3-031-27164-9_50
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-27163-2
Online ISBN: 978-3-031-27164-9
eBook Packages: MedicineReference Module Medicine